Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 4Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 4Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 51Neoplasms 34Colorectal Neoplasms 23Lung Neoplasms 17Prostatic Neoplasms 16Melanoma 15Neoplastic Cells, Circulating 13Pancreatic Neoplasms 11Multiple Myeloma 11Uterine Cervical Neoplasms 10Ovarian Neoplasms 10Carcinoma, Non-Small-Cell Lung 8Papillomavirus Infections 7Neoplasm Metastasis 7Leukemia, Myeloid, Acute 7Colonic Neoplasms 7Lymphoma, Follicular 6Lymphoma 6Hematologic Neoplasms 6Uveal Melanoma 5Sarcoma 5Head and Neck Neoplasms 5Glioma 5Uterine Cervical Dysplasia 4Urinary Bladder Neoplasms 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Glioblastoma 4Disease 4COVID-19 4

Interventions

Colposcopy 9Imiquimod 7Conization 7Papillomavirus Vaccines 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6Cryotherapy 6human papillomavirus vaccine, L1 type 16, 18 4Blood Specimen Collection 4Vaginal Smears 3Vaccines 3Papanicolaou Test 3VGX-3100 2Topotecan 2Proflavine 2Polymerase Chain Reaction 2Paclitaxel 2Mass Screening 2Human Papillomavirus DNA Tests 2Fluorouracil 2Cisplatin 2Biopsy 2Acetic Acid 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2terameprocol 1poly(gamma-glutamic acid) 1methyl 5-aminolevulinate 1lime 1human papillomavirus vaccine, TA 1hecolin 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Uterine Cervical Dysplasia × Blood Specimen Collection × Clear all
NCT06263582 2025-08-19

Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed
12 enrolled 18 charts
GynecologicLymphoid

Carcinoma in Situ, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Lymphoma, Follicular

NCT03355820 2020-11-19

A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study

GlaxoSmithKline

Phase 3 Completed
228 enrolled 11 charts
Gynecologic

Uterine Cervical Dysplasia

NCT00929526 2016-10-20

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

GlaxoSmithKline

Phase 3 Completed
752 enrolled 21 charts
Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT02016833 2015-04-30

Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

PX Biosolutions

Completed
15 enrolled
GynecologicMyeloidOther hematologic neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Leukemia, Ovarian Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡